EuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.

ENGINEERING IN LIFE SCIENCES, published by Wiley, is a pivotal journal for professionals, researchers, and students dedicated to advancing the interdisciplinary fields of bioengineering, biotechnology, and environmental engineering. With an ISSN of 1618-0240 and an E-ISSN of 1618-2863, this journal has established itself as a reputable platform for disseminating innovative research findings and breakthroughs in engineering applications within the life sciences. Currently holding a prestigious Q2 ranking in multiple categories, including bioengineering and environmental engineering, it reflects a strong commitment to high-quality, impactful research (Scopus ranks: Environmental Science - Rank #61/197, Biochemistry, Genetics and Molecular Biology - Rank #112/311). The journal spans contributions from 2004 to 2024, ensuring a comprehensive archiving of evolving scientific discourse. Although it does not currently offer open access, its curated articles are accessible through institutional and single-article purchases, providing valuable insights and updates for the academic community. Join us in shaping the future of engineering within life sciences and stay informed on critical advancements that are driving innovation across multiple disciplines.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

Industrial Biotechnology, published by Mary Ann Liebert, Inc., is a premier journal dedicated to the rapidly evolving field of biotechnology with a particular focus on its applications in industrial settings. Since its inception in 2006, this influential journal has been a vital resource for researchers and professionals keen on exploring innovative bioprocesses and the sustainable use of biological systems in industry. With an ISSN of 1550-9087 and an E-ISSN of 1931-8421, Industrial Biotechnology maintains a Q3 ranking in the biotechnology category, ranking 216 out of 311 in Scopus, signifying its growing impact in the field despite a current percentile rank of 30. This journal collects and disseminates significant findings that bridge the gap between science and technology, emphasizing ecological sustainability and economic viability in industrial practices. While offering traditional subscription options, it connects readers with cutting-edge advancements that shape modern biotechnology. As you delve into the pages of Industrial Biotechnology, expect to uncover groundbreaking research and pivotal insights that foster the advancement of this vital discipline.

AIMS Bioengineering, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing knowledge in the interdisciplinary field of bioengineering. With the ISSN 2375-1495, this journal has been providing a platform for the rapid dissemination of high-quality research since its establishment in 2014. AIMS Bioengineering covers a wide range of topics, including but not limited to, biomaterials, computational biology, and bioinformatics, making it an essential resource for researchers, professionals, and students alike. Although the H-index and specific category quartiles are not currently available, the journal's commitment to open access ensures that cutting-edge findings are accessible to a global audience, fostering collaboration and innovation in bioengineering. With its rigorous peer-review process and dedication to scholarly excellence, AIMS Bioengineering continues to play a pivotal role in shaping the future of the bioengineering landscape.

BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT is a leading open access journal published by TAYLOR & FRANCIS LTD from the United Kingdom, dedicated to advancing the field of biotechnology since its inception in 1990. Committed to disseminating high-quality research, the journal has transitioned to open access since 2014, enhancing its accessibility for researchers, professionals, and students alike. With a notable impact in the field, it is categorized in the Q3 quartile for Biotechnology as of 2023 and ranks #193 out of 311 in the Scopus categories for Biochemistry, Genetics, and Molecular Biology. The journal aims to cover a diverse range of topics related to both biotechnological advancements and the equipment that supports them, thus fostering innovative research and practical applications in the biotechnology sector. With an evolving scope that reflects the dynamic nature of biological research, BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT plays a crucial role in bridging the gap between laboratory studies and real-world applications, making it an essential resource for anyone involved in biotechnology research.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

Bioengineered, published by TAYLOR & FRANCIS INC, is an esteemed Open Access journal that has been at the forefront of research in the fields of bioengineering, biotechnology, and applied microbiology since its inception in 2012. With an impressive impact factor reflecting its high-quality contributions, the journal is categorized in the top quartiles, achieving Q1 rankings in Applied Microbiology and Biotechnology, as well as in Biotechnology and Medicine (Miscellaneous) for 2023. This active engagement in showcasing pioneering research is critical for professionals and students alike, facilitating access to revolutionary studies and methodologies. The journal operates under an Open Access model since 2018, ensuring that groundbreaking findings in bioengineering are readily accessible to a global audience. Situated in the United Kingdom, Bioengineered not only serves as a platform for innovative research but also underscores the importance of interdisciplinary collaborations among scientists, engineers, and biotechnologists.